1Koutsilieris M,Mitsiades C,Dimopoulos T,et al.Combination of dexamethasone and a somatostatin analogue in the treatment of advanced prostate cancer.Expert Opin Investig Drug,2002,11 (2):283-293.
2Meyerhof W.The elucidation of somatostatin receptor functions:a current view.Rev Physiol Biochem Phannaool,1998,133:55-108.
3Zapata P D,Ropero P M,Valencia A M,et al.Autocrine,regulation of human prostate carcinoma cell proliferation by somatostatin through the modulation of the SH2 domain containing protein tyrosine phosphatase (SHP)-1.J Clin Endocrinol Metab,2002,87(2):915-926.
4Szokoloczi O,Schwab R,Petak I,et al.TT232,a novel signal transduction inhibitory compound in the therapy of cancer and inflammatory diseases.J Recept Signal Transduct Res,2005,25(4-6):217-235.
5Schwab RE,Froidevaux S,Paku S,et al.Antiproliferative efficacy of the somatostatin analogue TT-232 in human melanoma cells and tumours.Anticancer Res,2001,21 (1A):71-75.
6Zalatnai A,Pogany V.Apoptosis-induction and phosphorylation state in human pancreatic carcinoma xenografts following octreotide treatment.Anticancer Res,2001,21 (1A):477-480.
7Garcia de la Torre N,Wass JA,Turner HE.Antiangiogenic effects of somatostatin analogues.Clin Endocrinol (Oxf),2002,57 (4):425-441.
8Florio T,Morini M,Villa V,et al.Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities.Endocrinology,2003,144 (4):1574-1584.
9Dasgupta P.Somatostatin analogues:multiple roles in cellular proliferation,neoplasia,and angiogenesis.Pharmacol Ther,2004,102 (1):61-85.
